Guided Therapeutics (GTHP) Profit After Tax (2010 - 2026)
Guided Therapeutics (GTHP) posted Profit After Tax of -$1.2 million for Q4 2025, down 64.15% sequentially from -$742000.0 in Q3 2025, and down 86.81% YoY from -$9.2 million in Q4 2024.
Guided Therapeutics (GTHP) Profit After Tax (2010 - 2026) Analysis & Trends
Guided Therapeutics has reported Profit After Tax for 16 years, with the latest figure at -$1.2 million in Q4 2025.
- Quarterly Profit After Tax fell 86.81% year-over-year to -$1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.8 million (down 37.51% YoY) and the FY2025 annual result came in at -$3.2 million, down 32.23% from the prior year.
- Profit After Tax fell to -$1.2 million in Q4 2025 per GTHP's latest filing, from -$742000.0 in the prior quarter.
- Over five years, Profit After Tax peaked at $68000.0 in Q3 2021 and troughed at -$1.8 million in Q4 2022.
- A 5-year average of -$727241.4 and a median of -$693000.0 in 2023 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2022 and 2024: Profit After Tax slumped 1720.59% in 2022, then surged 99.95% in 2024.
- Over 5 years, Profit After Tax stood at -$444000.0 in 2021, then slumped by 306.98% to -$1.8 million in 2022, then jumped by 78.64% to -$386000.0 in 2023, then slumped by 68.91% to -$652000.0 in 2024, then plunged by 86.81% to -$1.2 million in 2025.
- According to Business Quant data, Profit After Tax over the past three periods registered -$1.2 million, -$742000.0, and -$811000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 241.90 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 573.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 619.54 Mn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | -605,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -605,000.00 |
| Dec 31, 2025 | -1.22 Mn |
| Sep 30, 2025 | -742,000.00 |
| Jun 30, 2025 | -811,000.00 |
| Mar 31, 2025 | -427.00 |
| Dec 31, 2024 | -652,000.00 |
| Sep 30, 2024 | -654,000.00 |
| Jun 30, 2024 | -709,000.00 |
| Mar 31, 2024 | -402.00 |
| Dec 31, 2023 | -386,000.00 |
| Sep 30, 2023 | -677,000.00 |
| Jun 30, 2023 | -1.56 Mn |
| Mar 31, 2023 | -869,000.00 |
| Dec 31, 2022 | -1.81 Mn |
| Sep 30, 2022 | -1.10 Mn |
| Jun 30, 2022 | -926,000.00 |
| Mar 31, 2022 | -507,000.00 |
| Dec 31, 2021 | -444,000.00 |
| Sep 30, 2021 | 68,000.00 |
| Jun 30, 2021 | -1.03 Mn |